Company Filing History:
Years Active: 1997
Title: Srini Kaveri: Innovator in Biochemical Reactions
Introduction
Srini Kaveri is a notable inventor based in Villejuif, France. He has made significant contributions to the field of biochemistry, particularly in the development of autoantibodies that enhance the rate of chemical reactions. His work has implications for various biochemical processes and therapeutic applications.
Latest Patents
Kaveri holds a patent for "Autoantibodies which enhance the rate of a chemical reaction." This patent describes autoantibodies capable of catalyzing the hydrolysis of peptide bonds in the neurotransmitter vasoactive intestinal peptide (VIP). The patent details the preparation and use of these autoantibodies, highlighting their ability to hydrolyze radiolabeled thyroglobulin and other substrates. The hydrolytic activity of these antibodies is characterized by specific kinetic properties, making them a valuable tool in biochemical research.
Career Highlights
Kaveri is associated with Igen, Inc., where he continues to explore innovative solutions in biochemistry. His research has led to advancements in understanding how autoantibodies can be utilized to catalyze chemical reactions, which may have far-reaching effects in medical and scientific fields.
Collaborations
Some of his notable coworkers include Sudhir Paul and Lan Li. Their collaborative efforts contribute to the ongoing research and development in the field of biochemical innovations.
Conclusion
Srini Kaveri's work exemplifies the intersection of innovation and biochemistry. His patent on autoantibodies showcases the potential for enhancing chemical reactions, paving the way for future advancements in the field.